Search results
-
Drug Royalty Corporation Inc.
(416) 863-1865Royal Bank Plaza South Tower 200 Bay Suite 3120 Box 122, M5J 2J3 TorontoToronto based DRUG ROYALTY provides innovative royalty financing to companies, inventors, and institutions engaged in the development of pharmaceutical products, diagnostics or medical devices.
-
Cannasat is developing cannabinoid-based pharmaceutical products using proprietary formulation and drug delivery technologies. These products have broad therapeutic applications which include the treatment of neuropathic pain, chronic pain, depression, anxiety and movement disorders.
-
The board of directors, management and advisors of Protagenic Therapeutics consist of individuals with substantial industry, scientific and clinical experience who bring a wealth of pharmaceutical product discovery and development as well as financial expertise to the company.
-
In some situations, Pharmilink Healthcare Marketing Services may work with third parties who provide services including but not limited to provision of internet services, data analysis and manipulation, data keying and a variety of other services. Personal information may be shared or gathered by t…
-
DRI Capital is a pioneer and global leader in healthcare investing and was the original innovator of the healthcare royalty market. The firm, originally called Drug Royalty Corporation, was founded in 1992 to purchase royalty streams on pharmaceutical products and to make healthcare equity investme…